Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback